Abstract
Herpes simplex virus continues to be a leading cause of chronic corneal opacification and unilateral blindness. No similar studies have been previously conducted in the United Kingdom. A 12-question circular was posted to 903 consultant ophthalmologists. It evaluated treatment pattern of primary and recurrent epithelial and stromal keratitis. Treatment strategies were more uniform than expected, agreeing with Herpetic Eye Disease Study guidelines in the treatment of epithelial and stromal keratitis, but showing deviation in the use of antiviral agents for recurrent disease. The UK clinical practice for treating herpetic eye disease is consistent but deviates from Herpetic Eye Disease Study guidelines in some areas. Increased awareness of HEDS data could address this issue.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
